Lava Therapeutics Competitors and Similar CompaniesClear all
Lava Therapeutics's competitors and similar companies include Tetherex, Medivir, Anavex and Shanghai Henlius Biotech.
 Lava Therapeutics Lava Therapeutics is a biotech company that develops T-cell engagers for the therapy of solid tumors and hematologic malignancies. |  Tetherex Tetherex Pharmaceuticals Corp is a biopharmaceutical company focused on development of therapeutics for the treatment of inflammation, thrombosis and tumor metastasis across a broad range of severe diseases. |  Medivir Medivir is a company that researches, develops, and sells pharmaceuticals primarily for the treatment of oncology. |  Anavex Anavex is a biopharmaceutical company developing drugs for the treatment of cancer and neurological diseases. |  Shanghai Henlius Biotech Shanghai Henlius Biotech provides clinical-stage biopharmaceutical services.
| |
Founding Date | Founding Date 2016 | Founding Date 2014 | Founding Date 1988 | Founding Date 2006 | Founding Date 2009 |
Type | Type Public | Type Private | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Utrecht, NL HQ Philadelphia, US | Locations Oklahoma City, US HQ Morrisville, US | Locations Huddinge, SE HQ | Locations New York, US HQ Reno, US | Locations HQ |
Employees | Employees 34 | Employees N/A | Employees 9 | Employees 1623% increase | Employees 1273% increase |
Valuation ($) | Valuation ($) 53.4 m | Valuation ($) N/A | Valuation ($) 39.2 m | Valuation ($) 484.6 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $12m (FY, 2024) | Revenue (est.) N/A | Revenue (est.) kr8.5m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $12m (FY, 2024) | Gross profit N/A | Gross profit kr8.5m (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income ($25.1m) (FY, 2024) | Net income N/A | Net income (kr94.4m) (FY, 2025) | Net income ($46.4m) (FY, 2025) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 43m (about 8 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 156m (almost 8 years ago) |
Total funding raised | Total funding raised $ 102.8m | Total funding raised $ 46.2m | Total funding raised N/A | Total funding raised $ 12.6m | Total funding raised $ 346m |
For sources of this data, please see the company profile
View Company Profiles
Tetherex
HQ
Oklahoma City, US
Tetherex Pharmaceuticals Corp is a biopharmaceutical company focused on development of therapeutics for the treatment of inflammation, thrombosis and tumor metastasis across a broad range of severe diseases.
View companyMedivir
HQ
Huddinge, SE
Employees
9
Medivir is a company that researches, develops, and sells pharmaceuticals primarily for the treatment of oncology.
View companyAnavex
HQ
New York, US
Employees
16↑ 23% increase
Anavex is a biopharmaceutical company developing drugs for the treatment of cancer and neurological diseases.
View companyShanghai Henlius Biotech
HQ
Employees
127↑ 3% increase
Shanghai Henlius Biotech provides clinical-stage biopharmaceutical services.
View company